NextPlat NXPL
NASDAQ NXPL
$9.13 -0.30 (-3.18%)
At close: Sep 4, 2026 · 4:00 PM EDT

NextPlat (NXPL) Total Current Liabilities (2010 - 2026)

NextPlat's (NXPL) quarterly Total Current Liabilities came in at $11.0 million in Q2 2026, up 76.9% year-over-year from $6.2 million in Q2 2025, and up 20.84% quarter-over-quarter from $9.1 million in Q1 2026.

Analysis

NextPlat (NXPL) Total Current Liabilities (2010 - 2026) Analysis & Trends

NextPlat (NXPL) has reported Total Current Liabilities for 15 consecutive years, with $11.0 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Total Current Liabilities rose 76.9% year-over-year to $11.0 million in Q2 2026; TTM through Jun 2026 was $11.0 million, a 76.9% increase from a year earlier, with the FY2025 full-year figure at $9.1 million, up 11.16% from the prior year.
  • Total Current Liabilities was $11.0 million for Q2 2026 at NextPlat, up from $9.1 million in the prior quarter.
  • Over five years, Total Current Liabilities peaked at $16.0 million in Q1 2024 and troughed at $1.5 million in Q3 2022.
  • A 5-year average of $7.6 million and a median of $8.3 million in 2024 frame the typical range for Total Current Liabilities.
  • Across the five-year window, Total Current Liabilities surged 901.31% in 2023 and slumped 51.31% in 2025, its largest moves.
  • Over 5 years, Total Current Liabilities stood at $2.1 million in 2022, then soared by 590.45% to $14.2 million in 2023, then plunged by 42.33% to $8.2 million in 2024, then gained by 11.16% to $9.1 million in 2025, then rose by 20.34% to $11.0 million in 2026.
  • The last three Total Current Liabilities figures came in at $11.0 million (Q2 2026), $9.1 million (Q1 2026), and $9.1 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Teva Pharmaceutical Industries 42.34 Bn 38.68 Bn 2.15 Bn 15.65 Bn
2 Viatris 19.39 Bn 18.50 Bn 1.46 Bn 6.35 Bn
3 Dr Reddys Laboratories 9.99 Bn 9.85 Bn 396.53 Mn 1.66 Bn
4 Amneal Pharmaceuticals 5.57 Bn 5.53 Bn 334.51 Mn 883.19 Mn
5 Bausch Health Companies 2.45 Bn 1.58 Bn 2.10 Bn 4.54 Bn
6 Ani Pharmaceuticals 1.70 Bn 1.34 Bn 165.89 Mn 283.66 Mn
7 Alvotech 1.66 Bn 1.52 Bn 2.56 Mn 331.18 Mn
8 Amphastar Pharmaceuticals 985.90 Mn 695.77 Mn 93.47 Mn 263.21 Mn
9 Fennec Pharmaceuticals 434.07 Mn 392.82 Mn 17.15 Mn 12.39 Mn
10 NextPlat 24.77 Mn 12.93 Mn 4.69 Mn 10.98 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 10.98 Mn
Mar 31, 2026 9.09 Mn
Dec 31, 2025 9.13 Mn
Sep 30, 2025 7.36 Mn
Jun 30, 2025 6.21 Mn
Mar 31, 2025 8.42 Mn
Dec 31, 2024 8.21 Mn
Sep 30, 2024 9.67 Mn
Jun 30, 2024 12.75 Mn
Mar 31, 2024 15.95 Mn
Dec 31, 2023 14.24 Mn
Sep 30, 2023 14.69 Mn
Jun 30, 2023 1.79 Mn
Mar 31, 2023 2.33 Mn
Dec 31, 2022 2.06 Mn
Sep 30, 2022 1.47 Mn
Jun 30, 2022 1.51 Mn
Mar 31, 2022 1.71 Mn
Dec 31, 2021 2.78 Mn
Sep 30, 2021 1.24 Mn